McDowell PJ, Diver S, Yang F, et al.; Medical Research Council: Refractory Asthma Stratification Programme (RASP-UK Consortium).

Title: The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.

Citation: Lancet Respir Med
2021;9:1174–1184.

Country: UK | Indication: Asthma

This is an independent study

http://tago.ca/33971168
Scan to access the publication or visit
http://tago.ca/33971168